SCHEMBL6017638

SCHEMBL6017638

NCCCn1ccnc1-c1ncc[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 2/20 0.38
ALDH1A1 P00352 3/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
MTOR P42345 1/20 0.36
ADK P55263 1/20 0.36
TLR8 Q9NR97 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KCNH2 Q12809 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
ESR1 P03372 1/20 0.34
KCNK13 Q9HB14 1/20 0.34
BRD4 O60885 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9255222 0.81 ALDH1A1 (0.47) ALDH1A1KMT2APOLBTLR8CYP1A2
SCHEMBL5047485 0.79 NISCH (0.36) NISCHALDH1A1KMT2APOLBMTOR
SCHEMBL11011484 0.75 NISCH (0.38) NISCHALDH1A1KMT2APOLBMTOR
SCHEMBL15822692 0.75 ESR1 (0.35) ALDH1A1KMT2APOLBTLR8CYP3A4
SCHEMBL462620 0.74 ESR1 (0.60) ALDH1A1KMT2APOLBCYP3A4CYP2C9
SCHEMBL28796695 0.74 NISCH (0.40) NISCHALDH1A1KMT2AMTORADK
SCHEMBL9369328 0.72 HSD17B10 (0.55) NISCHALDH1A1KMT2AMTORADK
SCHEMBL137042 0.71 ALDH1A1 (0.69) ALDH1A1KMT2APOLBTLR8CA12
SCHEMBL3534451 0.71 BRD4 (0.46) NISCHALDH1A1KMT2AMTORADK
SCHEMBL6709692 0.70 ALDH1A1 (0.41) ALDH1A1KMT2APOLBTLR8ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1675578-A2 USE OF EFFECTORS OF GLUTAMINYL AND GLUTAMATE CYCLASES Probiodrug AG (DE) 2006-07-05 EP disclosed
WO-2005039548-A2 USE OF EFFECTORS OF GLUTAMINYL AND GLUTAMATE CYCLASES PROBIODRUG AG (DE) 2005-05-06 WO disclosed